A Kimi logo is seen on a screen at the
A Kimi logo is seen on a screen at the Moonshot AI stand, featuring the Kimi K3 model. HECTOR RETAMAL/Getty Images

Run the math on Moonshot AI's newest funding round and it comes out to roughly 167 times revenue. That is the price-to-sales multiple implied by the $50 billion pre-money valuation the Kimi chatbot maker has been seeking in the private round it closed in late August — a figure independently reported by several Chinese financial outlets over the past six weeks — measured against the roughly $300 million in annualized recurring revenue Moonshot had booked as of mid-June, the most recent figure the company has let slip.

That gap sat behind Tuesday's headlines. LatePost(晚点) reported that Moonshot had confidentially submitted an A1 form to the Hong Kong Stock Exchange this week, formally opening an IPO process. Several other outlets picked up the report within hours. Moonshot's own response was neither a confirmation nor a denial: the company said it does not comment on market rumors and has nothing to disclose at this time. That answer carries some history. A similar report in early August, claiming Moonshot would file within days to raise roughly $3 billion, prompted the company to call the story flatly untrue. Confidential filings under Hong Kong's Chapter 18C regime for specialist technology companies also don't show up on the exchange's public disclosure site until much later in the process, so the absence of anything on HKEX's own filing list neither confirms nor rules out what LatePost reported.

What isn't in dispute is the trajectory that got Moonshot here. Its annualized revenue crossed $100 million in March, doubled to $200 million by May, and tripled to roughly $300 million by mid-June — largely on the back of API and enterprise business, which industry trackers say now makes up more than 70% of the total. That growth curve, not the K3 model's benchmark scores, is what convinced management to abandon a "no rush to list" stance the founder had voiced as recently as December. A $3.5 billion round closed July 29 at a $35 billion post-money valuation, oversubscribed more than three times its original target with China's national AI investment fund among the backers. The pre-IPO round now targets a pre-money mark roughly 40% above that.

The nearest comparisons sit one exchange over. Zhipu and MiniMax listed in Hong Kong back-to-back in early January, and both stumbled once early lock-ups expired mid-year — meaning Moonshot would be following an established path, not opening one, whatever its own IPO materials might suggest. The two also show how differently the same industry can price. Zhipu's revenue, historically weighted toward government and state-enterprise deployments, has reportedly grown roughly 15-fold year over year to surpass $1 billion, pulling its own valuation multiple down toward the low double digits — well under a third of what Moonshot's round implies. Huang Lichong, president of Hong Kong-based Sumsion International Capital, cautioned last month that the widely floated six-month listing timeline is best read as an optimistic case rather than a fixed schedule, noting only that Moonshot is restructuring its offshore holding company and has held talks with Goldman Sachs and CICC. DeepSeek, which closed a roughly $7 billion round in June and is separately weighed as an IPO candidate, offers a further data point on how much capital this cohort can now pull in without a listing at all.

None of that settles whether $50 billion is the right number. It does mean the multiple Moonshot is asking investors to accept is unusually exposed to what a prospectus, if one is filed, will have to show: audited revenue, the real cost of serving the inference demand that briefly forced Moonshot to pause new K3 subscriptions this summer, and how much of that 70%-plus API revenue is durable enterprise usage rather than developer traffic that could shift to a cheaper model overnight. That filing, whenever it becomes public rather than confidential, is the document that will do what no exclusive report can.